Literature DB >> 32395054

A Survey of Emergency Providers Regarding the Current Management of Anterior Shoulder Dislocations.

D N Baden1, M H Roetman2, T Boeije1, N Mullaart-Jansen1, M D Burg3.   

Abstract

BACKGROUND: Anterior shoulder dislocations (ASDs) are frequent painful injuries commonly treated in the emergency department. The last decade new potentially less traumatic and painful reduction techniques for ASDs have been introduced. Recent literature comparing best reduction techniques, medication use, and approaches is limited. To better guide future research including the use of these newer techniques, information about the current use of different reduction techniques and medication is needed.
METHODS: Our primary aim was to survey the techniques used by emergency practitioners to reduce ASDs. Our secondary objective was to gather data on medication usage during reduction. To these ends, we surveyed members of the Netherlands Society of Emergency Physicians.
RESULTS: Forty-four percent of respondents reported using a traction-based technique (Hippocrates or Stimson). Biomechanical techniques were used by 40% of respondents. Twelve percent reported using the Kocher leverage-based technique. Five percent of the techniques used could not be classified. A wide variety of procedural sedation and pain management interventions were reported, with an opioid and propofol being used most commonly. Approximately 9% of the reductions were attempted without any medications.
CONCLUSIONS: To our knowledge, this is the first study of its kind on ASD management by emergency practitioners. Our results indicate that Dutch emergency practitioners employ all three classes of reduction techniques: traction-countertraction most commonly, closely followed by biomechanical techniques. Medication use during repositioning varied widely. Per our survey, emergency practitioners are desirous of an evidence-based guideline for ASD management. Copyright:
© 2020 Journal of Emergencies, Trauma, and Shock.

Entities:  

Keywords:  Anterior shoulder dislocation; biomechanical reduction techniques; emergency department; glenohumeral dislocation

Year:  2020        PMID: 32395054      PMCID: PMC7204951          DOI: 10.4103/JETS.JETS_87_18

Source DB:  PubMed          Journal:  J Emerg Trauma Shock        ISSN: 0974-2700


INTRODUCTION

Anterior shoulder dislocations (ASDs) are commonly managed by emergency practitioners.[1] However, little unambiguous scientific evidence exists about optimal ASD reduction techniques and medication use to effect such reductions. More than 50 ASD reduction techniques are described, making it difficult to determine a “best” technique or approach for each ASD encountered.[23] In preparation for such a study, and to narrow the options for a randomized controlled trial, it would be helpful to know the techniques and medications most commonly used presently. Two studies do exist comparing ASD reduction techniques most commonly used by orthopedic surgeons.[45] However, these data cannot necessarily be extrapolated to emergency department (ED) practice by emergency practitioners. In an attempt to shed some light on this knotty subject, we surveyed ASD repositioning techniques used by emergency physicians (EPs) and emergency medicine residents (EMRs). We also assessed “backup plans” in cases with first-attempt failure and medication usage. In addition, we sought to determine the interest level of emergency practitioners in an evidence-based medicine (EBM) ASD management guideline.

METHODS

In late 2015, Netherlands Society of Emergency Physicians (NSEP) members were E-mailed a Survey Monkey® web link with reminders E-mailed 1 and 2 months later. The questionnaire was sent to 587 individual members and contained nine questions in Dutch covering: techniques used, shoulder reduction experience, medications used, and the perceived need for an evidence-based ASD management guideline [Figure 1 for full questionnaire, translated into English]. IP addresses are automatically logged in Survey Monkey®. Questions could not be left unanswered without a reason, and the questionnaire could not be submitted if any question remained unanswered. All open-ended responses were reviewed by two of the authors (conception and study design, coordinator of project, coordination, and writing of manuscript) to check the spelling of the techniques or match a description with a technique. If there was no consensus or the technique was not known and could not be found in the literature, it was cataloged as “others.” Results were analyzed with IBM SPSS Statistics for Windows, Version 21.0. Realsed 2012; (Armonk, NY, USA: IBM Corp.), released 2012. We used frequency tables for the techniques and medications used. We did cross tables for experience compared to medication, experience compared to education, and interest in an EBM guideline compared to experience. Because this study surveyed physicians, no ethical approval was needed per Dutch law.
Figure 1

Questionnaire translated from Dutch

1. What is your function?
 Emergency physician
 Resident emergency medicine
 Other
2. Experience in repositioning anterior shoulder dislocation?
 <10
 10–50
 50–100
 >100
3. Is there a protocol in your hospital for the repositioning of anterior shoulder dislocation?
 Yes
 No
4. Preferred first technique used in the repositioning of anterior shoulder dislocation?
 Free text
5. Preferred second technique used in the repositioning of anterior shoulder dislocation?
 Free text
6. Medication commonly used in the repositioning of anterior shoulder dislocation?
 None
 Nonsteroidal anti-inflammatory drugs (NSAIDs) Fentanyl intravenous Fentanyl intranasal Morphine intravenous Midazolam
 Propofol Esketamine
 Diazepam Lidocaine intra-articular
 Free text
7. Estimated first time success?
 <50%
 50-75%
 75-95%
 >95%
8. Did you ever encounter complications during the repositioning of an anterior shoulder dislocation?
 Yes
 No
 Free text for explanation
9. Would you like to have an evidence-based guideline for the repositioning of anterior shoulder dislocation?
 Yes
 No
Questionnaire translated from Dutch

RESULTS

Respondents numbered 158–112 EPs (71%) and 46 EMRs (29%). Nearly two-thirds of the respondents claimed to have reduced >50 ASDs. In first reduction attempts, traction-based techniques (Hippocrates 25.3%, Stimson 18.4%) predominated slightly at 43.7%. Biomechanical repositioning techniques were used first by 39.2% of the respondents (Cunningham 23.4%, Milch 11.4%, and scapular manipulation 4.4%). These techniques depend on muscular relaxation without the application of force and include the Cunningham, modified Milch, scapular manipulation, and the FARES technique.[12345] Kocher's leverage technique was used by 12.0%, and 5.1% of techniques could not be classified [Table 1]. Table 2 lists the second techniques used if a first reduction attempt failed. In this circumstance, emergency practitioners used traction-based techniques 39.9% of the time, biomechanical techniques 32.4% of the time, and leverage techniques 19% of the time. A second technique was omitted in 4.4% of surveys, and 4.4% of the techniques used were not specified. We did comparisons between EP and EMR practice patterns, but these differences were not statistically significant.
Table 1

First technique used for reduction

TechniqueFrequency (%)
Hippocratic40 (25.3)
Cunningham37 (23.4)
Stimson29 (18.4)
Kocher19 (12.0)
Modified Milch18 (11.4)
Scapula Tilt7 (4.4)
Others8 (5.1)
Total158 (100.0)
Table 2

Second technique used for reduction

TechniqueFrequency (%)
Hippocratic43 (27.2)
Kocher30 (19.0)
Modified Milch20 (12.7)
Stimson20 (12.7)
Scapula Tilt17 (10.8)
Cunningham14 (8.9)
No second technique7 (4.4)
Others7 (4.4)
Total158 (100.0)
First technique used for reduction Second technique used for reduction Twenty-three percent of respondents reported a >95% first-attempt success rate. Approximately 80% of all practitioners indicated a >75% first-attempt success rate. Table 3 lists medications used to facilitate reduction. Multiple answers were allowed (e.g. morphine and propofol). Nearly 9% of respondents indicated no medication usage. An opioid (e.g., fentanyl or morphine) was the most commonly used analgesic and propofol the most commonly used sedative.
Table 3

Medication used (multiple responses possible)

MedicationResponses, n (%)
Intra-articular lidocaine100 (26.3)
Fentanyl intravenous81 (21.3)
NSAID51 (13.4)
Propofol44 (11.6)
None34 (8.9)
Fentanyl nasal29 (7.6)
Midazolam18 (4.7)
Esketamine13 (3.4)
Morphine intravenous9 (2.4)
Diazepam1 (0.3)
Total380 (100.0)

NSAID: Nonsteroidal anti-inflammatory drugs

Medication used (multiple responses possible) NSAID: Nonsteroidal anti-inflammatory drugs Forty-four percent of respondents indicated that their hospital had an ASD reduction protocol. Physician awareness of protocol existence did not significantly affect choice of reduction method. Seventy-four percent of respondents indicated that an evidence-based ASD guideline would be helpful [Table 4]. This interest was most pronounced in the least-experienced physicians.
Table 4

Interest for guideline compared to number of reductions performed

Number of reductions performedEBM guideline wantedTotal

YesNo
<10
 Number of responses707
 Percentage of group100.00.0100.0
10-50
 Number of responses361147
 Percentage of group76.623.4100.0
50-100
 Number of responses46955
 Percentage of group83.616.4100.0
>100
 Number of responses242044
 Percentage of group54.545.5100.0
Total
 Number of responses11340153
 Percentage of total73.926.1100.0

EBM: Evidence-based medicine

Interest for guideline compared to number of reductions performed EBM: Evidence-based medicine

DISCUSSION

To our knowledge, this is the first study of its kind on ASD management by emergency practitioners. Two earlier studies of orthopedic surgeons found that they relied heavily on traction- or leverage-based techniques.[67] In contrast, Dutch emergency practitioners employ a wider range of techniques. Biomechanical techniques, in particular, are more likely to be used by EPs and EMRs. Traction-based technique use does remain high among emergency practitioners, despite increased complication risk, particularly nerve damage.[89] Furthermore, leverage techniques are not without possible adverse effects, especially humeral spiral fractures in older patients or axillary vessel rupture.[1011] Continued use of these techniques may be due to a variety of factors including the lack of literature support for one particular technique, comparable success rates with a wide variety of techniques, familiarity with traction-based techniques, and most Dutch reduction protocols including only traction-countertraction and leverage-based techniques. Furthermore, these techniques cause pain and often mandate procedural sedation and analgesia as a consequence, causing prolonged ED lengths of stay.[121314] Our survey results indicated high interest in an evidence-based ASD reduction guideline. Furthermore, the negative effects of traction-based technique and leverage techniques (particularly pain and the resultant need for medication with its attendant prolonged ED stay, among others) may argue for such guideline. This point is of course countered by the lack of evidence favoring the use of any one technique or series of techniques. Although the “first attempt” was undefined in our survey, respondents reported a high first-attempt success rate. This is in keeping with other literature showing success rates in general for ASD reductions of 60%–100% regardless of approach.[9] Medication use by our respondents spanned the usual spectrum described in the present medical literature.[1516171819202122] Surprisingly, nitrous oxide use was not reported. Furthermore, surprising was the high use of intra-articular lidocaine (27%). Our respondent's reliance on propofol probably stems from its status as the “drug of choice” in the NSEP's procedural sedation and analgesia guideline. As a result of this study and the available literature, we think that randomized high-quality prospective trials are needed to provide more evidence on optimal ASD repositioning techniques. Further studies on optimal medication use for ASD reductions are needed as well. Taken together, these new bodies of knowledge could form the basis for an evidence-based ASD management guideline since there is substantial interest in such guidance. A randomized trial covering all ASD reduction techniques would be logistically impossible due to the wide range of techniques available. However, narrowing study focus to the commonly used biomechanical techniques with their more favorable adverse-effect profile could be both fruitful and feasible. We are tantalized by our experience that suggests a high repositioning success rate, a better patient experience, less medication use, and a shorter ED length of stay with biomechanical technique reduction use.

Limitations

Our survey is hampered by its reliance on practitioner memory and self-report. Because no supporting documentation is demanded for survey answers, it is possible that answers to key survey questions are incorrect. In addition, the direction and magnitude of this possible “incorrectness” are impossible for us to ascertain. No cookies were used to identify unique users, and the link was not password protected. However, because a limited group received the E-mail, no incentive was included, and the survey was voluntary, it would be highly unlikely that the same person repeatedly completed a questionnaire or shared the questionnaire with others to complete. We did check to see if any IP address had unusually high returns but did not find that occurrence. Survey Monkey® cannot report survey view rates, but we reasonably expected that if physicians opened the link, they also completed the questionnaire. Because we did not perform a presurvey pilot, it is possible that respondents interpreted the questions differently from our intention. This misinterpretation is also possible with the description or terms that the respondents provided for the techniques they use in repositioning. There is a risk that the participants used a different term or meant a different technique. We also omitted some follow-up questions to keep the questionnaire brief, to limit survey completion time, and to attempt to increase the number of respondents. As a result, the information gathered may be insufficient to capture all the details of emergency practitioner approach to ASD. ASD management complications were rarely reported by survey respondents limiting our ability to draw conclusions about this. It is also possible that underreporting, late complications or post-ED discharge complications occurred that would not be captured by our survey. Our relatively low survey response rate of 27% may limit our ability to draw statistically valid conclusions. However, we did receive responses from 66% of Dutch EDs, representing a continuum of teaching hospitals, academic and community hospitals, and high- and low-volume institutions. We did collect data from a broad spectrum of Dutch emergency practitioners and only completed questionnaires are included. Furthermore, recent research shows that a low survey response rate does not necessarily directly reduce result quality.[23] This study involved only Dutch EPs and EMRs, thus making it difficult to generalize these findings. The nature of health care in The Netherlands is comparable to that of other western countries, but it may not reflect on the practice in other health-care systems.[24]

CONCLUSIONS

Our survey demonstrated that Dutch EPs and EMRs most commonly use traction-countertraction techniques for ASD reduction. They also commonly use biomechanical techniques as well. Medication use to effect reduction and control pain, relief distress, and achieve muscle relaxation varies widely. ASD management guidelines are strongly desired by emergency practitioners. These three findings should help shape the direction of future ASD management research.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  22 in total

1.  Intra-articular lignocaine versus Entonox for reduction of acute anterior shoulder dislocation.

Authors:  A P Gleeson; C A Graham; A D Meyer
Journal:  Injury       Date:  1999-08       Impact factor: 2.586

2.  From Hippocrates to the Eskimo--a history of techniques used to reduce anterior dislocation of the shoulder.

Authors:  A Mattick; J P Wyatt
Journal:  J R Coll Surg Edinb       Date:  2000-10

3.  Dislocation of the shoulder complicated by rupture of the axillary vessels.

Authors:  J R KIRKER
Journal:  J Bone Joint Surg Br       Date:  1952-02

4.  Technical note: modifications and improvements of the Milch technique for the reduction of anterior dislocation of the shoulder without premedication.

Authors:  C Garnavos
Journal:  J Trauma       Date:  1992-06

Review 5.  Anterior shoulder dislocation: a review of reduction techniques.

Authors:  G D Riebel; J B McCabe
Journal:  Am J Emerg Med       Date:  1991-03       Impact factor: 2.469

6.  Comparison of intra-articular lidocaine and intravenous sedation for reduction of shoulder dislocations: a randomized, prospective study.

Authors:  Suzanne L Miller; Edmond Cleeman; Joshua Auerbach; Evan L Flatow
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

7.  Anesthetic methods for reduction of acute shoulder dislocations: a prospective randomized study comparing intraarticular lidocaine with intravenous analgesia and sedation.

Authors:  J Kosnik; F Shamsa; E Raphael; R Huang; Z Malachias; G M Georgiadis
Journal:  Am J Emerg Med       Date:  1999-10       Impact factor: 2.469

8.  Scapular manipulation for reduction of anterior shoulder dislocations.

Authors:  D Anderson; R Zvirbulis; J Ciullo
Journal:  Clin Orthop Relat Res       Date:  1982-04       Impact factor: 4.176

9.  Reduction of traumatic secondary shoulder dislocations with lidocaine.

Authors:  P A Suder; J B Mikkelsen; K Hougaard; P E Jensen
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

10.  Etomidate and midazolam for reduction of anterior shoulder dislocation: a randomized, controlled trial.

Authors:  John H Burton; Anthony J Bock; Tania D Strout; Evie G Marcolini
Journal:  Ann Emerg Med       Date:  2002-11       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.